These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24719184)

  • 1. Synchronous versus metachronous brain metastasis from testicular germ cell tumors (TGCT): an analysis from the Spanish Germ Cell Cancer Group data base.
    Girones R; Aparicio J; Roure P; Germa-Lluch JR; García Del Muro X; Vazquez-Estevez S; Saenz A; Sastre J; Arranz Arija J; Gallardo E; Gonzalez-Billalabeitia E; Sanchez-Hernandez A; Terrasa J; Hernandez A; Santander C; Cillan E; Sagastibelza N; Almenar-Cubells D; Lopez Brea M; Maroto JP;
    Clin Transl Oncol; 2014 Nov; 16(11):959-65. PubMed ID: 24719184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of brain metastases from germ cell tumors.
    Oechsle K; Bokemeyer C
    Hematol Oncol Clin North Am; 2011 Jun; 25(3):605-13, ix. PubMed ID: 21570612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracranial metastasis of testicular germ cell tumours.
    Shah Z; Bashir HH; Bakhshi SK; Shamim MS
    J Pak Med Assoc; 2023 May; 73(5):1137-1139. PubMed ID: 37218255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain metastasis from non-seminomatous germ cell tumors of the testis: indications for aggressive treatment.
    Salvati M; Piccirilli M; Raco A; Santoro A; Frati R; Lenzi J; Lanzetta G; Agrillo A; Frati A
    Neurosurg Rev; 2006 Apr; 29(2):130-7. PubMed ID: 16328533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
    Fizazi K; Pagliaro L; Laplanche A; Fléchon A; Mardiak J; Geoffrois L; Kerbrat P; Chevreau C; Delva R; Rolland F; Theodore C; Roubaud G; Gravis G; Eymard JC; Malhaire JP; Linassier C; Habibian M; Martin AL; Journeau F; Reckova M; Logothetis C; Culine S
    Lancet Oncol; 2014 Dec; 15(13):1442-1450. PubMed ID: 25456363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of brain metastases in patients with testicular cancer.
    Bokemeyer C; Nowak P; Haupt A; Metzner B; Köhne H; Hartmann JT; Kanz L; Schmoll HJ
    J Clin Oncol; 1997 Apr; 15(4):1449-54. PubMed ID: 9193339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of relapse in poor-prognosis germ-cell tumours in the GETUG 13 trial: Implications for assessment of brain metastases.
    Loriot Y; Pagliaro L; Fléchon A; Mardiak J; Geoffrois L; Kerbrat P; Chevreau C; Delva R; Rolland F; Theodore C; Roubaud G; Gravis G; Eymard JC; Malhaire JP; Linassier C; Habibian M; Martin AL; Journeau F; Reckova M; Logothetis C; Laplanche A; Le Teuff G; Culine S; Fizazi K
    Eur J Cancer; 2017 Dec; 87():140-146. PubMed ID: 29149760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment and Outcome of Patients with Stage IS Testicular Cancer: A Retrospective Study from the Spanish Germ Cell Cancer Group.
    Aparicio J; Sánchez-Muñoz A; Ochenduszko S; Gumà J; Fernández-Aramburo A; García Del Muro X; Quiroga V; Sastre J; Alonso-Gordoa T; Sagastibelza N; Maroto P; Gómez de Liaño A; Vázquez S; Diz P; Durán I; Domenech M; Pinto A; Hernández A; González-Billalabeitia E; Terrasa J
    J Urol; 2019 Oct; 202(4):742-747. PubMed ID: 31163007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical features of patients with brain metastasis from testicular germ cell tumor].
    Matsuda Y; Tanaka T; Sato S; Kitamura H; Takahashi S; Masumori N; Tsukamoto T
    Hinyokika Kiyo; 2010 Feb; 56(2):99-102. PubMed ID: 20185995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a subgroup with worse prognosis among patients with poor-risk testicular germ cell tumor.
    Kojima T; Kawai K; Tsuchiya K; Abe T; Shinohara N; Tanaka T; Masumori N; Yamada S; Arai Y; Narita S; Tsuchiya N; Habuchi T; Nishiyama H
    Int J Urol; 2015 Oct; 22(10):923-7. PubMed ID: 26094715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-dense chemotherapy for untreated poor-prognosis and relapsed germ-cell tumours: an 18-year experience with GAMEC chemotherapy.
    Shamash J; Mee M; Sarker SJ; Wilson P; Ansell W; Greenwood M; Berney D; Alifrangis C
    BJU Int; 2020 Jun; 125(6):843-852. PubMed ID: 31688976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain metastases from testicular germ cell tumors: a retrospective analysis.
    Nonomura N; Nagahara A; Oka D; Mukai M; Nakai Y; Nakayama M; Nishimura K; Kakimoto K; Nakamura T; Usami M; Okuyama A; Miki T
    Int J Urol; 2009 Nov; 16(11):887-93. PubMed ID: 19863625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastasectomy as optimal treatment for late relapsing solitary brain metastasis from testicular germ cell tumor: a case report.
    Iida K; Naiki T; Kawai N; Ando R; Etani T; Tozawa K; Kohri K
    BMC Res Notes; 2014 Dec; 7():865. PubMed ID: 25444462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain metastases and testicular tumors: long-term survival.
    Spears WT; Morphis JG; Lester SG; Williams SD; Einhorn LH
    Int J Radiat Oncol Biol Phys; 1992; 22(1):17-22. PubMed ID: 1370066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive chemotherapy in poor-prognosis nonseminomatous germ cell tumors of the testis.
    Germá Lluch JR; Seguí Palmer MA; Climent Durán MA; Blanco Guerrero R; Fernández Sagarra A; Villavicencio H; Solé Balcells FJ
    Eur Urol; 1992; 21(4):287-93. PubMed ID: 1333957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decision Making in a Data-Poor Environment: Management of Brain Metastases From Testicular and Extragonadal Germ Cell Tumors.
    Gilligan T
    J Clin Oncol; 2016 Feb; 34(4):303-6. PubMed ID: 26668343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic impact of different tumor marker levels in nonseminomatous germ cell tumor patients with intermediate prognosis: A registry of the International Global Germ Cell Tumor Collaborative Group (G3).
    Seidel C; Daugaard G; Tryakin A; Necchi A; Cohn-Cedermark G; Ståhl O; Hentrich M; Brito M; Albany C; Taza F; Gerl A; Oechsle K; Oing C; Bokemeyer C
    Urol Oncol; 2019 Nov; 37(11):809.e19-809.e25. PubMed ID: 31494007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First salvage treatment in patients with advanced germ cell cancer after cisplatin-based chemotherapy: analysis of a registry of the German Testicular Cancer Study Group (GTCSG).
    Berger LA; Bokemeyer C; Lorch A; Hentrich M; Kopp HG; Gauler TC; Beyer J; de Wit M; Mayer F; Boehlke I; Oing C; Honecker F; Oechsle K
    J Cancer Res Clin Oncol; 2014 Jul; 140(7):1211-20. PubMed ID: 24696231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of surgery, chemotherapy and irradiation on long term outcome of intracranial malignant non-germinomatous germ cell tumors: results of the German Cooperative Trial MAKEI 89.
    Calaminus G; Bamberg M; Jürgens H; Kortmann RD; Sörensen N; Wiestler OD; Göbel U
    Klin Padiatr; 2004; 216(3):141-9. PubMed ID: 15175958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors.
    Einhorn LH; Williams SD; Chamness A; Brames MJ; Perkins SM; Abonour R
    N Engl J Med; 2007 Jul; 357(4):340-8. PubMed ID: 17652649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.